BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22833926)

  • 21. Cell-penetrating peptides as tools to enhance non-injectable delivery of biopharmaceuticals.
    Kristensen M; Nielsen HM
    Tissue Barriers; 2016; 4(2):e1178369. PubMed ID: 27358757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CPP-Assisted Intracellular Drug Delivery, What Is Next?
    Ye J; Liu E; Yu Z; Pei X; Chen S; Zhang P; Shin MC; Gong J; He H; Yang VC
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smart Cell-Penetrating Peptide-Based Techniques for Intracellular Delivery of Therapeutic Macromolecules.
    He Y; Li F; Huang Y
    Adv Protein Chem Struct Biol; 2018; 112():183-220. PubMed ID: 29680237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer.
    Bolhassani A
    Biochim Biophys Acta; 2011 Dec; 1816(2):232-46. PubMed ID: 21840374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1988-2018: Thirty years of drug smuggling at the nano scale. Challenges and opportunities of cell-penetrating peptides in biomedical research.
    Gallo M; Defaus S; Andreu D
    Arch Biochem Biophys; 2019 Jan; 661():74-86. PubMed ID: 30447207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers.
    Kebebe D; Liu Y; Wu Y; Vilakhamxay M; Liu Z; Li J
    Int J Nanomedicine; 2018; 13():1425-1442. PubMed ID: 29563797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
    Reissmann S
    J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-penetrating peptides in protein mimicry and cancer therapeutics.
    Zorko M; Jones S; Langel Ü
    Adv Drug Deliv Rev; 2022 Jan; 180():114044. PubMed ID: 34774552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
    Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
    Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential of cell-penetrating peptides (CPPs) in delivery of antiviral therapeutics and vaccines.
    Sadeghian I; Heidari R; Sadeghian S; Raee MJ; Negahdaripour M
    Eur J Pharm Sci; 2022 Feb; 169():106094. PubMed ID: 34896590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noncovalently associated cell-penetrating peptides for gene delivery applications.
    Alhakamy NA; Nigatu AS; Berkland CJ; Ramsey JD
    Ther Deliv; 2013 Jun; 4(6):741-57. PubMed ID: 23738670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Current Role of Cell-Penetrating Peptides in Cancer Therapy.
    Feni L; Neundorf I
    Adv Exp Med Biol; 2017; 1030():279-295. PubMed ID: 29081059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptide vectors for the nonviral delivery of nucleic acids.
    Hoyer J; Neundorf I
    Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral biodrug delivery using cell-penetrating peptide.
    Khafagy el-S; Morishita M
    Adv Drug Deliv Rev; 2012 May; 64(6):531-9. PubMed ID: 22245080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-penetrating peptides: achievements and challenges in application for cancer treatment.
    Shin MC; Zhang J; Min KA; Lee K; Byun Y; David AE; He H; Yang VC
    J Biomed Mater Res A; 2014 Feb; 102(2):575-87. PubMed ID: 23852939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Applications of amphipathic and cationic cyclic cell-penetrating peptides: Significant therapeutic delivery tool.
    Sajid MI; Moazzam M; Stueber R; Park SE; Cho Y; Malik NUA; Tiwari RK
    Peptides; 2021 Jul; 141():170542. PubMed ID: 33794283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rational design of CPP-based drug delivery systems: considerations from pharmacokinetics.
    Mickan A; Sarko D; Haberkorn U; Mier W
    Curr Pharm Biotechnol; 2014; 15(3):200-9. PubMed ID: 25312539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-penetrating Peptides for Cancer-targeting Therapy and Imaging.
    Wang W; Abbad S; Zhang Z; Wang S; Zhou J; Lv H
    Curr Cancer Drug Targets; 2015; 15(4):337-51. PubMed ID: 25669720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Potential of cell penetrating peptides for cell drug delivery].
    Poillot C; De Waard M
    Med Sci (Paris); 2011 May; 27(5):527-34. PubMed ID: 21609675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current Delivery Strategies to Improve the Target of Cell Penetrating Peptides Used for Tumor-Related Therapeutics.
    Zhang F; Yang D; Jiang S; Wu L; Qin L; He H; Zhang P
    Curr Pharm Des; 2018; 24(5):541-548. PubMed ID: 28758600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.